Cancer Therapy Challenge: It Is Time to Look in the “St. Patrick’s Well” of the Nature
Open Access
- 26 September 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (19) , 10380
Abstract
Cancer still remains a leading cause of death despite improvements in diagnosis, drug discovery and therapy approach. Therefore, there is a strong need to improve methodologies as well as to increase the number of approaches available. Natural compounds of different origins (i.e., from fungi, plants, microbes, etc.) represent an interesting approach for fighting cancer. In particular, synergistic strategies may represent an intriguing approach, combining natural compounds with classic chemotherapeutic drugs to increase therapeutic efficacy and lower the required drug concentrations. In this review, we focus primarily on those natural compounds utilized in synergistic approached to treating cancer, with particular attention to those compounds that have gained the most research interest.Keywords
This publication has 179 references indexed in Scilit:
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancerCancer Chemotherapy and Pharmacology, 2013
- Cannabinoids, endocannabinoids, and cancerCancer and Metastasis Reviews, 2011
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancerFree Radical Biology and Medicine, 2011
- Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53European Journal of Cancer, 2010
- Resveratrol attenuates the anticancer efficacy of paclitaxel in human breast cancer cells in vitro and in vivoEuropean Journal of Cancer, 2010
- Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerInternational Journal of Cancer, 2009
- Multitargeted therapy of cancer by green tea polyphenolsCancer Letters, 2008
- Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitorInternational Journal of Cancer, 2008
- Recent Advances on the Molecular Mechanisms Involved in the Drug Resistance of Cancer Cells and Novel Targeting TherapiesClinical Pharmacology & Therapeutics, 2007
- Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectivesPhytochemistry, 2006